The Biden administration’s push to introduce widespread Covid-19 vaccine boosters faces a test as a Food and Drug Administration advisory panel meets to weigh evidence on the extra shots, a topic that has divided federal health officials.

The outside panel of about 20 scientific advisers is set to review information Friday about the Pfizer Inc. and BioNTech SE vaccine’s declining protection against Covid-19 over time and on how people tolerated additional doses. It will hear presentations from Pfizer, which has asked regulators to clear booster shots for people 16 years and older, and the FDA, which this week said all the shots cleared for use in the U.S. remain effective without boosters. The panel will also consider contrasting scientific data about the extra shots.

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Snapchat Parent Launches Monthly Subscription Plan

Snap is launching a subscription plan that unlocks exclusive features on the…

MrBeast stirs backlash after asking fans to fix Walmart displays for his Feastables chocolate bars

Jimmy Donaldson, the stunt YouTuber better known as MrBeast, tweeted an unconventional…

Global Chip Shortage Set to Worsen for Car Makers

Global auto makers who had expected the semiconductor supply crisis to subside…

Ron DeSantis signs Florida bill limiting the liabilities of private spaceflight companies

Florida Gov. Ron DeSantis on Thursday signed into law a spaceflight bill…